US Patent Issued to NANOBIOSYM on Oct. 7 for "Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents" (Massachusetts Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,351, issued on Oct. 7, was assigned to NANOBIOSYM INC. (Cambridge, Mass.).

"Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents" was invented by Anita Goel (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "One aspect of the invention provides a system for drug discovery, drug development, drug screening, or drug validation. The system includes: a sample chamber comprising a target protein and a drug candidate that may interfere with the target protein in the sample chamber, wherein the sample chamber is configured to: detect one or more of the f...